Publications by authors named "Jennifer Fine"

Claim this Profile
A
Association of Echocardiographic Parameters and Health Status in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM.
Suzanne V Arnold, Kensey L Gosch, Chantal Dolan, Jennifer T Fine, Ahmad Masri

Circulation· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary Challenges in Polycythemia Vera Management From the Perspective of Patients and Physicians.
Andrew T Kuykendall, Jennifer T Fine, Marina Kremyanskaya

Clin Lymphoma Myeloma Leuk· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States.
Srihari S Naidu, Megan B Sutton, Wei Gao, Jennifer T Fine, Jipan Xie

J Med Econ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes, Resource Utilization, and Treatment Over the Disease Course of Symptomatic Obstructive Hypertrophic Cardiomyopathy in the United States.
Nihar R Desai, Megan B Sutton, Jipan Xie, Jennifer T Fine, Wei Gao

Am J Cardiol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Kansas City Cardiomyopathy Questionnaire in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Michael Nassif, Jennifer T Fine, Chantal Dolan, Matthew Reaney, Prithvi Addepalli

JACC Heart Fail· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial.
Matthew Reaney, Prithvi Addepalli, Veleka Allen, John A Spertus, Chantal Dolan, Jennifer T Fine

Pharmacoecon Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Changes, Healthcare Resource Utilization, and Costs Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Claims Database Study.
Anjali T Owens, Megan B Sutton, Wei Gao, Jennifer T Fine, Jipan Xie

Cardiol Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health Benefit.
Nihar Desai, Jipan Xie, Yan Wang, Megan B Sutton, John Whang, Jennifer T Fine

Clin Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial.
Jipan Xie, Yan Wang, Yaping Xu, Jennifer T Fine, Jenny Lam

J Med Econ· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States.
Sneha S Jain, Sophia S Li, Jipan Xie, Megan B Sutton, Jennifer T Fine

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
John A Spertus, Jennifer T Fine, Perry Elliott, Carolyn Y Ho, Iacopo Olivotto

Lancet· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOdified NARanjo Causality Scale for ICSRs (MONARCSi): A Decision Support Tool for Safety Scientists.
Shaun Comfort, Darren Dorrell, Shawman Meireis, Jennifer Fine

Drug Saf· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media.
Shaun Comfort, Sujan Perera, Zoe Hudson, Darren Dorrell, Shawman Meireis, Jennifer Fine

Drug Saf· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Drug Development: Integrating the Patient Perspective Into Early Research.
Anthony J Yanni, Jennifer Fine

Ther Innov Regul Sci· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mental health leadership and patient access to care: a public-private initiative in South Africa.
Christopher Paul Szabo, Jennifer Fine, Pat Mayers, Shan Naidoo, Tuviah Zabow

Int J Ment Health Syst· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of and risk factors for diabetic macular edema in the United States.
Rohit Varma, Neil M Bressler, Quan V Doan, Michelle Gleeson, Mark Danese, Jennifer Fine

JAMA Ophthalmol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A survey on the treatment of atrial fibrillation in South Africa.
R M Jardine, Jennifer Fine, I W P Obel

S Afr Med J· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States.
Neil M Bressler, Rohit Varma, Quan V Doan, Michelle Gleeson, Mark Danese, Jennifer Fine

JAMA Ophthalmol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab.
Neil M Bressler, Tom S Chang, Rohit Varma, Ivan Suñer, Paul Lee, Jennifer Fine

Ophthalmology· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author response: Validation of the National Eye Institute Visual Function Questionnaire-25 (NEIVFQ-25) in age-related macular degeneration.
Peggy Orr, Anne M Rentz, Mary Kay Margolis, Dennis A Revicki, Chantal M Dolan, Jennifer T Fine

Invest Ophthalmol Vis Sci· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration.
Peggy Orr, Anne M Rentz, Mary Kay Margolis, Dennis A Revicki, Chantal M Dolan, Jennifer T Fine

Invest Ophthalmol Vis Sci· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).
Claudia Trenkwalder, Bryan Kies, Monika Rudzinska, Jennifer Fine, Janos Nikl

Mov Disord· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR.
Neil M Bressler, Tom S Chang, Ivan J Suñer, Jennifer T Fine, Chantal M Dolan

Ophthalmology· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial.
Neil M Bressler, Tom S Chang, Jennifer T Fine, Chantal M Dolan, James Ward

Arch Ophthalmol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial.
Tom S Chang, Neil M Bressler, Jennifer T Fine, Chantal M Dolan, James Ward

Arch Ophthalmol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis